Houlihan Lokey Inc (HLI)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Houlihan Lokey Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 125.50 $ — 0% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
10/10 Quality stockThe AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 13.0%
- Exp. sales growth 3Y > 5% 9.5%
- EBIT growth 10Y > 5% 14.6%
- Exp. EBIT growth 3Y > 5% 19.1%
- Net debt < 4x EBIT -1.4x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 44.2%
- Return on equity > 15% 57.3%
- ROCE > 15% 20.0%
- Expected return > 10% 28.5%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
7 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 13.1% failed
- More than 10% revenue growth is expected for the coming year 13.2% passed
- Share count grows by less than 3% a year 0.4% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 35.6% failed
- Gross margin at 40% or higher and without meaningful erosion 98.4% passed
- Goodwill from acquisitions does not grow faster than revenue 32.4% passed
- Net debt below twice EBITDA 868 m net cash passed
- Operating cash flow covers the profits of the last three years 775 m passed
- Return on capital at 15% or higher, or up versus two years ago 20.0% passed
- Insiders hold at least 10% or are net buyers 0.1% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 21.9% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 9
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 03/31/2027 | 6.99 | 6.65 – 7.47 | 2,628 | -7.6% | 9 |
| 03/31/2028 | 8.83 | 8.00 – 9.95 | 3,138 | 26.4% | 11 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.39 | 32.90 | 634 | 24.10 | 15.00 | 266 | 262 |
| 2025: Q1 | 1.76 | 48.90 | 666 | 28.00 | 18.30 | 358 | 344 |
| 2025: Q2 | 1.42 | 9.00 | 605 | 17.90 | 16.10 | -132 | -145 |
| 2025: Q3 | 1.63 | 19.20 | 660 | 14.70 | 17.00 | 325 | 323 |
| 2025: Q4 | 1.70 | 22.90 | 717 | 13.00 | 16.30 | 218 | 217 |
| 2026: Q1 | 1.47 | -16.80 | 636 | -4.60 | 15.70 | 293 | 287 |
| 2026: Q2 | 1.15 | -19.00 | 511 | -15.60 | 15.30 | -336 | -342 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 872 | 182 | 108 | 1.63 | 229 | 730 | 1,382 |
| 2018 | 963 | 214 | 172 | 2.60 | 251 | 853 | 1,419 |
| 2019 | 1,084 | 219 | 159 | 2.42 | 224 | 891 | 1,423 |
| 2020 | 1,159 | 230 | 184 | 2.80 | 288 | 984 | 1,677 |
| 2021 | 1,525 | 408 | 313 | 4.55 | 580 | 1,384 | 2,426 |
| 2022 | 2,270 | 613 | 438 | 6.41 | 737 | 1,444 | 2,887 |
| 2023 | 1,809 | 342 | 254 | 3.76 | 136 | 1,613 | 2,969 |
| 2024 | 1,914 | 363 | 280 | 4.11 | 328 | 1,837 | 3,171 |
| 2025 | 2,389 | 502 | 400 | 5.82 | 849 | 2,175 | 3,820 |
| 2026 | 2,618 | 619 | 426 | 6.22 | 704 | 2,342 | 4,309 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Houlihan Lokey, Inc. ist eine Investmentbank, die weltweit Dienste für Fusionen und Übernahmen (M&A), Kapitalmarkt, finanzielle Restrukturierung und Liability Management sowie Finanz- und Bewertungsberatung anbietet.
| Employees | 2,800 |
|---|---|
| Headquarters | Los Angeles, CA |
| Address | 10250 Constellation Boulevard, 90067 Los Angeles, United States |
| Phone | 310 553 8871 |
| Website | hl.com |
| IPO Date | 13. Aug 2015 |
| ISIN | US4415931009 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Craig E. Tessimond | Managing Director | – |
| Nana Kyei | Managing Director of Technology Group | – |
| Jacques Cornet | Investor Relations Professional | – |
| Charles A. Yamarone | Chief Corporate Governance & Compliance Officer | 1959 |
| Jeffrey Werbalowsky | Senior Managing Director | – |
| James Francis Lavelle | MD & Head of Corporate Coverage and Industrials | 1964 |
| Matthew R. Niemann | Managing Director | 1964 |
| Jay Novak | MD and Head of The Consumer, Food & Retail Group | – |
| Ranon Kent | MD & Global Head of Business Services Group | – |
| John George Mavredakis | Global Head of the Financial Sponsors Group & Senior MD | 1958 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.